- Trials with a EudraCT protocol (8)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
8 result(s) found for: Spinal Cord Independence Measure.
Displaying page 1 of 1.
| EudraCT Number: 2007-004358-10 | Sponsor Protocol Number: FARM6Y35XM | Start Date*: 2007-09-14 | |||||||||||
| Sponsor Name:AZIENDA OSPEDALIERA OSPEDALE NIGUARDA CA' GRANDA (A.O. DI RILIEVO NAZIONALE) | |||||||||||||
| Full Title: EVALUATION OF THE TOLERABILITY AND EFFICACY OF ERYTHROPOIETIN (EPO) TREATMENT IN SPINAL SHOCK: COMPARATIVE STUDY VS METHYLPREDNISOLONE (MP) | |||||||||||||
| Medical condition: PARAPLEGICS AND TETRAPLEGICS | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2015-005717-80 | Sponsor Protocol Number: FAB117-CT-01 | Start Date*: 2016-05-29 | ||||||||||||||||
| Sponsor Name:Ferrer Internacional S.A | ||||||||||||||||||
| Full Title: Clinical trial of phase 1/2 to evaluate the feasibility, safety, tolerability and preliminary efficacy of the administration of FAB117-HC, a drug whose active ingredient is HC016, allogeneic adipos... | ||||||||||||||||||
| Medical condition: Patients with acute traumatic spinal cord injury | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults | Gender: Male, Female | |||||||||||||||||
| Trial protocol: ES (Ongoing) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2011-005377-23 | Sponsor Protocol Number: SCI-GHD-201 | Start Date*: 2012-07-18 | ||||||||||||||||
| Sponsor Name:Guillem Cuatrecasas Cambra | ||||||||||||||||||
| Full Title: A phase II, single-center, prospective, randomized, double-blind, parallel and placebo-controlled pilot clinical study to assess the efficacy and safety of NUTROPIN® in combination with intensive r... | ||||||||||||||||||
| Medical condition: Spinal Cord Injury and Growth Hormone Deficiency | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults | Gender: Male, Female | |||||||||||||||||
| Trial protocol: ES (Completed) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2016-001227-31 | Sponsor Protocol Number: NISCI | Start Date*: 2019-06-19 | ||||||||||||||||
| Sponsor Name:University Zurich, University Hospital Balgrist, Spinal Cord Injury Center | ||||||||||||||||||
| Full Title: Antibodies against Nogo-A to enhance plasticity, regeneration and functional recovery after acute spinal cord injury | ||||||||||||||||||
| Medical condition: spinal cord injury | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: DE (Completed) CZ (Completed) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2013-000906-52 | Sponsor Protocol Number: SC0806-A101 | Start Date*: 2015-03-24 |
| Sponsor Name:BioArctic AB | ||
| Full Title: An Open, Randomized, Rehabilitation-controlled Study to Assess Safety, Tolerability, and Efficacy of Heparin Activated Recombinant Human Fibroblast Growth Factor 1 on a Biodegradable Device in Subj... | ||
| Medical condition: Complete Traumatic Spinal Cord Injury (TSCI) | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: SE (Prematurely Ended) NO (Completed) EE (Prematurely Ended) FI (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2012-004373-80 | Sponsor Protocol Number: ASBI603 | Start Date*: 2013-06-21 | |||||||||||
| Sponsor Name:Asubio Pharmaceuticals, Inc. | |||||||||||||
| Full Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SUN13837 Injection in Adult Subjects with Acute Spinal Co... | |||||||||||||
| Medical condition: Acute spinal cord injury | |||||||||||||
|
|||||||||||||
| Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) CZ (Completed) ES (Completed) PL (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2018-000805-22 | Sponsor Protocol Number: A2017SCI03 | Start Date*: 2019-06-11 |
| Sponsor Name:Neuroplast BV | ||
| Full Title: A multi-center, double-blind, randomized, placebo-controlled, delayed-start phase II/III study to assess the efficacy and safety of Neuro-Cells in (sub)acute spinal cord injury patients. | ||
| Medical condition: Traumatic spinal cord injury | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DK (Completed) ES (Ongoing) | ||
| Trial results: View results | ||
| EudraCT Number: 2019-002282-35 | Sponsor Protocol Number: rh-NGF | Start Date*: 2020-05-13 | |||||||||||
| Sponsor Name:FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS UNIVERSITA' CATTOLICA DEL SACRO CUORE | |||||||||||||
| Full Title: Nerve growth factor in pediatric severe traumatic brain injury : translational and clinical studies on a candidate biomarker and therapeutic drug | |||||||||||||
| Medical condition: Persistent unresponsive wakefulness syndrome (UWS) | |||||||||||||
|
|||||||||||||
| Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.